Teijin Ltd (3401):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Teijin Ltd (3401) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12139
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products, pharmaceuticals, medical devices and water purification systems. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, infectious and other diseases. Teijin operates facilities in America, Europe, Asia and Japan. The company sells its products in Asia, America, and Europe. Teijin is headquartered in Osaka, Japan.

Teijin Ltd (3401) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Teijin Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Teijin Ltd, Medical Equipment, Deal Details 10
Asset Purchase 10
Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 10
Partnerships 11
Teijin Enters into Licensing Agreement with Nativis 11
Teijin Pharma Enters into Distribution Agreement with SRETT 12
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 13
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 14
Debt Offering 15
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2018 15
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2021 16
Acquisition 17
Teijin to Acquire Controlling Stake in MedTech Heart from Seeds Rocket 17
Teijin to Acquire 86% of Implantable Medical Product Company of Takiron 18
Teijin Acquires 50% Stake in Nakashima Medical 19
Teijin Ltd – Key Competitors 20
Teijin Ltd – Key Employees 21
Teijin Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 25
Recent Developments 26
Financial Announcements 26
May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018 26
May 09, 2017: Teijin Reports Revenue Of JPY741.3 Billion In Fiscal 2017 29
Feb 06, 2017: TEIJIN:Consolidated Financial Statements For Nine Months Ended December 31 2016 30
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Teijin Ltd, Medical Equipment, Key Facts, 2018 2
Teijin Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Ltd, Deals By Market, 2012 to YTD 2018 8
Teijin Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 10
Teijin Enters into Licensing Agreement with Nativis 11
Teijin Pharma Enters into Distribution Agreement with SRETT 12
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 13
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 14
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2018 15
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2021 16
Teijin to Acquire Controlling Stake in MedTech Heart from Seeds Rocket 17
Teijin to Acquire 86% of Implantable Medical Product Company of Takiron 18
Teijin Acquires 50% Stake in Nakashima Medical 19
Teijin Ltd, Key Competitors 20
Teijin Ltd, Key Employees 21
Teijin Ltd, Other Locations 23
Teijin Ltd, Subsidiaries 23
Teijin Ltd, Joint Venture 25

List of Figures
Teijin Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Teijin Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Teijin Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Teijin Ltd (3401):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • EnviroMission Limited (EVM)-エネルギー分野:企業M&A・提携分析
    Summary EnviroMission Limited (Enviro) is a renewable energy company that develops Solar Tower Technology (STT). It owns the license to STT across the world (excluding in China). The STT integrates the use of solar air collector and central updraft tower, to generate solar induced convective flow. I …
  • Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報
    Summary Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, ther …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona) formerly Aniona, is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • Trellis Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trellis Bioscience Inc (Trellis) is a drug development company that discovers and develops human antibody therapeutics for the treatment of bacterial and viral infectious diseases and cancer indications. The company’s clinical candidate includes TRL1068, which targets and disintegrates bacte …
  • J.M. Huber Corporation:企業の戦略・SWOT・財務情報
    J.M. Huber Corporation - Strategy, SWOT and Corporate Finance Report Summary J.M. Huber Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MSD Pharmaceuticals Pvt Ltd (MSD India), a subsidiary of Merck & Co Inc, is a healthcare products provider that offers prescription medicines, vaccines, biologic therapies, and animal health products. The company offers pipeline products such as medicines, tablets, capsules, solutions, and p …
  • The McClatchy Company:企業の戦略・SWOT・財務情報
    The McClatchy Company - Strategy, SWOT and Corporate Finance Report Summary The McClatchy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Avacta Group Plc:企業のM&A・事業提携・投資動向
    Avacta Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Avacta Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Trinity Industries Inc (TRN)-エネルギー分野:企業M&A・提携分析
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • Alps Alpine Co Ltd (6770):企業の財務・戦略的SWOT分析
    Alps Alpine Co Ltd (6770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ABPA Holdings Ltd:企業の戦略的SWOT分析
    ABPA Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Under Armour Inc (UAA):企業の財務・戦略的SWOT分析
    Under Armour Inc (UAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Renova Energia SA (RNEW11)-エネルギー分野:企業M&A・提携分析
    Summary Renova Energia S.A. (Renova Energia) is a renewable power generation company. It develops, implements and operates power generation projects based on renewable energy sources such as wind, small hydropower and solar; and sells electricity. It also undertakes activities related to manufacturi …
  • Korea National Oil Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Korea National Oil Corp (KNOC) is a state-owned integrated oil company that carries out the exploration, development and production of oil and gas, and stockpiling of petroleum resources. The company purchases and sells crude oil, distribute gasoline and refined products. It also imports and …
  • Histogen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies based on the products of cells grown under simulated embryonic conditions. The company’s products include a soluble multipotent cell conditioned media and insoluble extracellular matrix. Its products are …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆